Galectin Therapeutics (GALT) Dividends payables (2010 - 2025)
Galectin Therapeutics' (GALT) quarterly Dividends payables came in at $63000.0 in Q4 2025, little changed year-on-year from $63000.0 in Q4 2024, and little changed quarter-over-quarter from $63000.0 in Q2 2025.
Galectin Therapeutics (GALT) Dividends payables (2010 - 2025) Analysis & Trends
Galectin Therapeutics' Dividends payables history runs 16 years deep, the most recent figure standing at $63000.0 for Q4 2025.
- On a quarterly basis, Dividends payables changed 0.0% year-over-year to $63000.0 in Q4 2025; TTM through Dec 2025 was $63000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $63000.0, changed 0.0% from the prior year.
- Dividends payables steadied at $63000.0 in Q4 2025 per GALT's latest filing, from $63000.0 in the prior quarter.
- Across five years, Dividends payables topped out at $65000.0 in Q2 2021 and bottomed at $63000.0 in Q4 2023.
- The 5-year median for Dividends payables is $63500.0 (2022), against an average of $63700.0.
- Across the five-year window, Dividends payables changed 0.0% in 2021 and fell 1.56% in 2023, its largest moves.
- Year by year, Dividends payables stood at $65000.0 in 2021, then fell by 1.54% to $64000.0 in 2022, then decreased by 1.56% to $63000.0 in 2023, then changed by 0.0% to $63000.0 in 2024, then changed by 0.0% to $63000.0 in 2025.
- Per Business Quant, the three latest GALT Dividends payables figures stand at $63000.0 (Q4 2025), $63000.0 (Q2 2025), and $63000.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Galectin Therapeutics | 227.21 Mn | 227.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Jun 30, 2024 | 63,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Jun 30, 2023 | 64,000.00 |
| Dec 31, 2022 | 64,000.00 |
| Jun 30, 2022 | 64,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Jun 30, 2021 | 65,000.00 |
| Dec 31, 2020 | 65,000.00 |
| Jun 30, 2020 | 66,000.00 |
| Dec 31, 2019 | 66,000.00 |
| Jun 30, 2019 | 66,000.00 |
| Dec 31, 2018 | 299,000.00 |
| Jun 30, 2018 | 67,000.00 |
| Dec 31, 2017 | 68,000.00 |
| Jun 30, 2017 | 68,000.00 |
| Dec 31, 2016 | 68,000.00 |
| Jun 30, 2016 | 68,000.00 |